Milan, Italy

Paola Petrillo



 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Paola Petrillo: Innovator in Chronic Pain Treatment

Introduction

Paola Petrillo is a notable inventor based in Milan, Italy. She has made significant contributions to the field of medicine, particularly in the treatment of chronic pain. With a total of 3 patents to her name, her work is paving the way for innovative therapeutic solutions.

Latest Patents

One of her latest patents focuses on the use of dimiracetam in the treatment of chronic pain. This patent discloses that at doses higher than those previously known for its cognition-enhancing activity, dimiracetam can completely revert hyperalgesia or allodynia in various animal models of chronic pain. The compound has shown high efficacy in treating iatrogenic neuropathies linked to antiviral and chemotherapeutic drug treatments, as well as painful conditions caused by osteoarthritis. Importantly, dimiracetam has demonstrated a lack of toxicity, even at doses ten times higher than the maximum therapeutic dose. This opens up the possibility of treating debilitating conditions with a highly effective and essentially non-toxic compound.

Career Highlights

Paola Petrillo is currently associated with Neurotune AG, where she continues her research and development efforts. Her innovative work in the medical field has garnered attention and respect from her peers.

Collaborations

Paola collaborates with esteemed colleagues, including Carlo Farina and Carla Ghelardini, who contribute to her research endeavors.

Conclusion

Paola Petrillo's contributions to the treatment of chronic pain through her innovative use of dimiracetam highlight her role as a leading inventor in the medical field. Her work not only advances scientific understanding but also offers hope for effective pain management solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…